+44 7971 853 043


Cornwall, TR3 6QA, United Kingdom

About Emerging Markets 

Emerging pharmaceutical markets are a US$350 billion opportunity, and now account for a quarter of the global market. Rising wealth, longer lifespans, and greater prevalence of chronic disease are driving growth – but market access is a sovereign policy area for governments and payers. Altarnum Consulting can help you navigate the local environment and tailor your global strategy to stakeholder needs in emerging markets.

Welcome to

Altarnum Consulting 

Focusing on high-growth, complex markets, we can help navigate the local environment and deliver favourable access. We operate in global markets outside North America and Western Europe.

Click the button below to find out more about us

Company Established
0 +
projects completed
0 +
Happy Clients

Specialising in emerging markets, our mission is Connecting healthcare companies and decision makers for emerging markets.



Latest Assignments

KOL expectations for a novel cancer therapy
Global Pharmaceutical Client

Payer research in a vaccine for Japan and emerging markets in Latin America
Global Pharmaceutical Client

© Altarnum Consulting.  All rights reserved. View our privacy policy.  Registered in England under the Companies Act, No. 07507546